Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 56 (D.Del. Apr. 25, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 56 (D.Del. Apr. 25, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 59 (D.Del. Apr. 25, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 59 (D.Del. Apr. 25, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, 1:17-cv-01065, No. 138-11 (D.Del. Jul. 20, 2018)
Cite Document
AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, 1:17-cv-01065, No. 138-11 (D.Del. Jul. 20, 2018)
+ More Snippets
Document
AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, 1:17-cv-01065, No. 138-12 (D.Del. Jul. 20, 2018)
Cite Document
AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, 1:17-cv-01065, No. 138-12 (D.Del. Jul. 20, 2018)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 55 (D.Del. Apr. 21, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 55 (D.Del. Apr. 21, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 54 (D.Del. Apr. 19, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 54 (D.Del. Apr. 19, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 52 (D.Del. Apr. 11, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 52 (D.Del. Apr. 11, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 1 (D.Del. Aug. 4, 2016)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 1 (D.Del. Aug. 4, 2016)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 50 (D.Del. Apr. 5, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 50 (D.Del. Apr. 5, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 49 (D.Del. Apr. 4, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 49 (D.Del. Apr. 4, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 48 (D.Del. Mar. 20, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 48 (D.Del. Mar. 20, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 47 (D.Del. Mar. 13, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 47 (D.Del. Mar. 13, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 46 (D.Del. Feb. 28, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 46 (D.Del. Feb. 28, 2017)
+ More Snippets
Document
IPR2017-01987, No. 11 Motion - PRO HAC VICE MOTION TO ADMITABIGAIL LANGSAM PURSUANT TO 37 CFR 4210c (P.T.A.B. Nov. 30, 2017)
Cite Document
IPR2017-01987, No. 11 Motion - PRO HAC VICE MOTION TO ADMITABIGAIL LANGSAM PURSUANT TO 37 CFR 4210c (P.T.A.B. Nov. 30, 2017)
+ More Snippets
Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 45 (D.Del. Feb. 10, 2017)
Cite Document
AbbVie Inc. et al v. Amgen Inc. et al, 1:16-cv-00666, No. 45 (D.Del. Feb. 10, 2017)
+ More Snippets